2.45BMarket Cap11.14P/E (TTM)
77.220High74.376Low490.25KVolume76.570Open75.660Pre Close37.03MTurnover1.53%Turnover Ratio10.13P/E (Static)32.51MShares158.61052wk High2.51P/B2.42BFloat Cap69.35052wk Low--Dividend TTM32.11MShs Float320.000Historical High--Div YieldTTM3.76%Amplitude0.680Historical Low75.524Avg Price1Lot Size
72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...
Steven J : I bought $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$ at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework